Loading
Procedure guide · Hair
Female Hair TransplantA female hair transplant moves follicles to thinning areas, most often a widening part, a receding temple or a high forehead. Women thin diffusely rather than in the male pattern, so the donor area is frequently affected too, which narrows who is suitable. A medical cause must be excluded first, because thyroid disease, iron deficiency and hormonal conditions cause loss that surgery cannot treat.
A female hair transplant moves follicles to thinning areas, and the operation itself is no different from the male version. What differs is who it suits, and the honest answer is far fewer women than men, for reasons that are worth understanding before spending money on a consultation.
Male pattern loss spares the back and sides, which is the entire basis of transplantation: follicles taken from there are genetically resistant to balding and stay resistant in their new position. Female pattern loss is frequently diffuse and affects the donor zone as well, so follicles harvested from it may already be miniaturising and will thin in their new position just as they would have done in the old one.
That is why a surgeon should examine the donor under magnification rather than assuming it is safe, and why a proportion of women who enquire are better served by medical treatment. A surgeon who declines to operate on that basis is applying the test that determines whether the operation can work at all.
Before any of it, the cause of the loss should be established. Women lose hair for many more reasons than men: thyroid disease, iron deficiency, polycystic ovary syndrome, medication, telogen effluvium after illness or childbirth, and scarring conditions such as frontal fibrosing alopecia and lichen planopilaris.
Several of those improve with treatment and none is helped by surgery. Transplanting into an active scarring alopecia is worse than useless, because the grafts are destroyed by the same process that destroyed the original follicles and donor hair is spent for nothing. A clinic that offers a woman surgery without blood tests and a proper history is selling a procedure rather than treating a condition.
Where surgery does work well is on defined targets rather than diffuse thinning. A naturally high forehead, recessed temples, traction alopecia from years of tight styles, and scars from previous surgery or injury all have a clear goal and usually reliable donor hair. Those are the cases that satisfy.
Diffuse thinning across the top of the scalp is the hardest thing to treat surgically, because it is precisely the pattern in which the donor is also likely to be affected. Minoxidil does more for that than surgery does, and a realistic consultation says so.
Most women have unshaven or partially shaven sessions, with a donor patch hidden under the hair above it, which keeps the procedure discreet. That is slower work, so fewer grafts are moved in a day and the cost per graft is higher, and it is worth knowing the trade rather than assuming discretion is free.
Finally, design. A female hairline is generally lower, rounder and less angular than a male one, without the temporal recession that is normal in men, and with a soft irregular edge. A design borrowed from male pattern work looks wrong on a woman’s face, which is a concrete reason to ask how many women a surgeon treats and to look at photographs of them specifically.
Telogen effluvium deserves particular mention because it is so often mistaken for pattern loss and so often treated surgically when it should not be. It is a diffuse shed triggered by illness, surgery, childbirth, significant weight loss or severe stress, it appears some months after the trigger, and it usually recovers on its own over six to twelve months.
Operating on it wastes donor hair on an area that was going to recover anyway, and does so at a point when the whole scalp is in an unstable state. A surgeon who asks what was happening in your life six months before the shedding started is asking exactly the right question.
Where the donor is marginal, scalp micropigmentation deserves consideration rather than being treated as a lesser option. Tattooed dots reduce the contrast between pale scalp and darker hair, which is much of what makes diffuse thinning visible, and they use no donor hair at all. For a woman whose donor cannot safely be harvested, it may be the most useful tool available.
A practical point about the donor patch: most women have a small area shaved beneath the hair above it, and how well that is hidden depends on where it is placed and how you wear your hair. Ask to be shown the intended position in a mirror before it is shaved, particularly if you often wear your hair up.
Expectations about styling are worth setting explicitly. A transplant adds hair to a defined area; it does not thicken the whole scalp. Women frequently describe the goal in terms of a parting that no longer shows scalp, or being able to wear their hair back, and framing it that way produces a more useful conversation than a graft number does.
Finally, medical treatment is not an optional extra here in the way patients sometimes assume. Female pattern loss continues regardless of surgery, and a transplanted area surrounded by hair that keeps thinning looks progressively odder. Minoxidil is the mainstay; other options exist and should be decided with a doctor who knows your full history rather than by a surgical clinic.
Surgeons look for these points at the consultation.
A female hair transplant suits women with a defined target such as a high hairline, recessed temples or traction alopecia, with a stable donor area that is not itself thinning, whose loss has been investigated and any medical cause treated, and who have realistic expectations of added density rather than restoration.
Reasons a good surgeon will ask you to wait or choose something else.
A female hair transplant is avoided in untreated thyroid disease, iron deficiency or hormonal conditions, in diffuse thinning that also affects the donor area, in active frontal fibrosing alopecia or lichen planopilaris, in telogen effluvium that may recover on its own, and where loss is still progressing rapidly.
Ask your surgeon which technique they recommend for you and why.
Grafts are placed between existing hairs without shaving the recipient area, with a donor patch hidden under the hair above it.
Grafts placed to rebuild recessed temples or lower a high frontal hairline, which is one of the more predictable uses of surgery in women.
A strip taken from the occipital scalp and closed as a line, hidden under long hair, which avoids shaving and preserves donor capacity.
Minoxidil, spironolactone or other treatments directed at the diagnosis, which is the first-line approach for most female pattern loss.
Step by step, from arrival to discharge.
Before a female hair transplant, thyroid function, iron and ferritin are checked and a history taken, since several causes of female hair loss are treatable and none is helped by surgery.
The back and sides are assessed for miniaturisation, because harvesting from a donor that is itself thinning gives poor yield and visible depletion.
The hairline is drawn lower, rounder and softer than a male one, without temporal recession, and approved before any incision is made.
A donor patch is shaved and hidden under the hair above it, which gives clear sight of follicle angles while keeping the procedure discreet.
Grafts are placed among existing hair without shaving the recipient area, which is slower but avoids any visible sign of surgery.
Minoxidil or another treatment appropriate to the diagnosis is planned, since surgery does not stop the underlying loss.
Frequencies follow published guidance; your personal risk depends on your health and the surgeon.
The most important risk in a female hair transplant is having the operation at all when the diagnosis has not been made. Women lose hair for many more reasons than men do: thyroid disease, iron deficiency, polycystic ovary syndrome, medication, telogen effluvium after illness or childbirth, and scarring conditions such as frontal fibrosing alopecia. Several of those improve with treatment and none is helped by surgery. Transplanting into active scarring alopecia is worse than useless, because the grafts are destroyed and donor hair is spent for nothing.
The second is donor quality. Male pattern loss spares the back and sides, which is what makes the operation work. Female pattern loss is frequently diffuse and affects the donor zone too, so follicles taken from there may be miniaturising already and will thin in their new position just as they would have done in the old one. A surgeon who examines the donor under magnification and declines to operate is applying the test that matters. Any clinic that offers a female patient surgery without blood tests and without examining the donor properly is selling an operation rather than treating a condition.
Surgery does not stop female pattern loss, so untransplanted hair keeps thinning unless medical treatment is used alongside.
Placing grafts among existing hair disturbs it, and after a female hair transplant this is more visible because the area was thinning rather than bald.
In female pattern loss the back and sides are frequently affected too, so harvesting from a donor that is itself thinning gives poor yield and visible depletion.
A female hair transplant adds hair to a thinning area rather than restoring youthful density, and patients expecting the latter are frequently disappointed.
Inflamed spots around growing grafts in the months afterwards, usually settling on their own and occasionally needing antibiotics.
A female hairline is rounder and lower than a male one, and a design borrowed from male pattern work looks wrong on a woman’s face.
Transplanting into active scarring alopecia destroys the grafts and wastes donor hair. This is why diagnosis before surgery matters more in women than in men.
Most women choose an unshaven or partially shaven session, so the recovery is discreet from the outset: forehead swelling in the first days is the most visible sign, and the recipient area is hidden among existing hair. Washing is fiddlier than on a shaved scalp and takes longer, and following the clinic’s demonstration closely matters as much as it does for any transplant.
The shedding phase is harder here than in male pattern work, and it is worth preparing for. Transplanted hairs fall out at 2 to 4 weeks, and some of the existing hair disturbed during placement sheds as well, so an area that was thin can briefly look thinner. It recovers over 3 to 6 months. Women treating diffuse thinning rather than a bald patch feel this more acutely, which is one reason honest expectation-setting before surgery matters so much.
Days 1-3
Forehead swelling peaks around day 3. The first wash is usually done at the clinic. Where nothing was shaved, there is little else to see.
Days 4-10
Crusting loosens with gentle washing, which is fiddlier among unshaved hair. Most women are presentable throughout, with hair arranged to cover the area.
Weeks 2-4
Transplanted hairs fall out, and some existing hair may shed too. This is the hardest phase for patients treating thinning rather than baldness.
Months 3-6
New hairs emerge and any shock loss recovers. Coverage at 6 months is roughly half the final result.
Months 12-18
Density settles and the added hair blends with the existing. A female hair transplant should be judged at this point.
A female hair transplant adds density to a defined area, most reliably at a high hairline, recessed temples or an area of traction alopecia.
The practical gain most women describe is about styling: being able to wear the hair back, or part it where they want to.
Diffuse thinning improves less than patients hope, because the donor for it is frequently affected by the same process.
The result takes 12 to 18 months, with regrowth from 3 to 4 months and roughly half the final density at 6 months.
A female hair transplant is usually unshaven or partially shaven, which is slower work and therefore priced above a standard male session for the same graft count.
The costs that sit outside the package are the investigations: blood tests and any dermatological opinion are arranged and paid for at home. A clinic that requires them before agreeing to operate is doing the right thing rather than adding hurdles.
Budget for medical treatment as an ongoing cost. Surgery treats the area operated on, and without treatment the surrounding hair continues to thin, which erodes the result.
Why quotes for the same procedure differ, so you can compare packages fairly.
Options to weigh before deciding, surgical and non-surgical.
Minoxidil and, where appropriate, other treatments directed at the diagnosis. The first-line approach for most female pattern loss and the only thing that helps diffuse thinning.
Where the forehead is high, the hair dense and there is no pattern balding, advancing the whole hairline achieves more than grafting can.
The discreet session format most women choose, with grafts placed among existing hair.
Where tight styling caused the loss, stopping it can recover some hair without surgery and is necessary before any grafting is worthwhile.
Ask the same questions at every consultation so you can compare answers.
Because of the donor area. Male pattern loss spares the back and sides, which is what makes moving follicles work. Female pattern loss is often diffuse and thins the donor zone as well, so follicles taken from there may already be miniaturising.
A follicle that was going to thin in its original position will thin in its new one too. That is why a surgeon should examine the donor under magnification rather than assuming it is safe, and why a proportion of women who enquire are better served by medical treatment.
Before a female hair transplant, at minimum: thyroid function, iron and ferritin, and a review of medication and any recent illness, pregnancy or significant weight loss. Hormonal conditions such as polycystic ovary syndrome should be considered where the pattern suggests it.
The reason is that several common causes of hair loss in women improve with treatment and none improves with surgery. A clinic offering an operation without blood tests and a proper history is skipping the step that determines whether surgery is appropriate at all.
A female hair transplant treats defined targets rather than diffuse thinning: a high forehead, recessed temples, traction alopecia from years of tight styles, and scars from previous surgery or injury. Those have reliable donor hair nearby and a clear goal.
Diffuse thinning across the top of the scalp is the hardest thing to treat surgically, because it is exactly the pattern in which the donor may also be affected. Medical treatment does more for that than surgery does.
A female hair transplant usually leaves the recipient area unshaven. Most women have unshaven or partially shaven work, with a donor patch hidden under the hair above it, which keeps the procedure discreet.
The trade is that unshaven work is slower, so fewer grafts are moved in a session and the cost per graft is higher. Where a very large number of grafts is needed, a surgeon may recommend shaving a donor strip or discussing FUT instead.
Traction alopecia, a common reason for a female hair transplant, is loss caused by prolonged pulling on the hair, from tight ponytails, braids, weaves or extensions. It typically affects the hairline and temples and is one of the more treatable patterns surgically.
The condition must be inactive first, which means stopping the styles that caused it, otherwise the transplanted hair will be pulled out in turn. A surgeon should ask about styling history and may want to see stability over months before operating.
A female hair transplant can lower a hairline by adding grafts in front of it, which suits a naturally high forehead and gives a soft, natural edge. It is one of the more predictable uses of surgery in women.
Where the forehead is very high and the hair density good, hairline lowering surgery moves the whole hairline forward in one operation and achieves more than grafting can. The two treat the same complaint quite differently and are worth comparing.
Medication is needed after a female hair transplant almost always, because surgery treats the area operated on and does nothing to stop the underlying loss elsewhere. Without treatment, a transplanted zone can end up surrounded by hair that has continued to thin.
Minoxidil is the mainstay for women. Finasteride is used off-label in some circumstances but is not appropriate for women who may become pregnant, and spironolactone is used in others. This should be decided with a doctor who knows your history rather than by the surgical clinic alone.
Yes, and it matters. A female hairline is generally lower, rounder and less angular than a male one, without the temporal recession that is normal in men, and with a soft irregular edge rather than a defined line.
A design borrowed from male pattern work looks wrong on a woman’s face, and this is a reason to ask specifically how many female patients a surgeon treats. Ask to see photographs of women rather than a gallery of male results.
Frontal fibrosing alopecia, which rules out a female hair transplant while active, is a scarring condition that causes the hairline to recede, often with loss of the eyebrows, and it destroys follicles permanently by replacing them with scar tissue. It is more common in women, particularly after menopause.
It matters because transplanting into active scarring alopecia fails: the grafts are destroyed by the same process and the donor hair is wasted. A dermatologist’s assessment, sometimes with a biopsy, is what distinguishes it from ordinary pattern loss, and surgery should wait until it is inactive if it is considered at all.
Graft numbers for a female hair transplant depend entirely on the target. Temple restoration or a modest hairline advance might take 1,000 to 2,000 grafts; adding density across a widening part takes considerably more and gives a less dramatic visible change.
The donor is the limit. Where the back and sides are themselves thinning, the safe number is lower than the area would otherwise justify, and a surgeon who reduces the plan on that basis is protecting both the result and the donor.
A female hair transplant can make the area look thinner temporarily, and women notice it more than men because the area was thinning rather than bald. Existing hair disturbed during placement can shed in the weeks afterwards, so a thin area briefly looks thinner.
It recovers over 3 to 6 months in most cases. Hair that was already miniaturising and near the end of its life sometimes does not return, which is another argument for medical treatment alongside surgery.
Ask how many women they treat, and ask to see photographs of female patients at 12 to 18 months with loss similar to yours. A clinic whose gallery is entirely male pattern work is not where to have a female hairline designed.
Then ask what investigations they require before agreeing to operate. A clinic that asks for blood tests and a dermatological opinion where the picture is unclear is treating a condition; one that books you straight in is selling a procedure.
Telogen effluvium is worth asking about before a female hair transplant, because the two are confused often and treated very differently. Telogen effluvium is a diffuse shed triggered by illness, surgery, childbirth, major weight loss or severe stress, appearing a few months after the trigger.
It usually recovers on its own over 6 to 12 months, so operating on it spends donor hair on an area that was going to improve anyway. A surgeon who asks what was happening in your life six months before the shedding began is asking the right question.
A female hair transplant does not thicken the whole scalp. It adds hair to a defined area, and the rest is unchanged. Women who arrive hoping for overall thickening are usually describing a goal that medical treatment addresses better than surgery.
Framing the goal concretely helps: a parting that no longer shows scalp, temples that frame the face, being able to wear the hair back. Those are achievable targets, and they make a more useful conversation than a graft number does.
Scalp micropigmentation is an option alongside a female hair transplant and deserves more consideration than it usually gets. Tattooed dots reduce the contrast between pale scalp and darker hair, which is much of what makes diffuse thinning visible, and they use no donor hair at all.
For a woman whose donor area is itself thinning and cannot safely be harvested, it may be the most useful tool available. It works best alongside existing hair rather than alone, and needs periodic maintenance as the pigment fades.
The donor patch for a female hair transplant is usually a small area at the back or side, shaved and hidden under the hair above it. How well it is concealed depends on placement and on how you wear your hair, particularly if you often wear it up.
Ask to be shown the intended position in a mirror before anything is shaved. It is a reasonable request, it takes a moment, and it prevents the fairly common disappointment of finding a patch that shows in a ponytail.
A female hair transplant can be done while on minoxidil, and most surgeons prefer it. It protects the hair around the transplanted area, which is what stops the result being surrounded by continuing thinning.
Clinics often ask patients to pause it for a short period immediately around surgery, because it can increase bleeding and scalp sensitivity, then resume. Follow the specific instruction rather than stopping indefinitely, since the benefit depends on continuous use.
A female hair transplant does not affect colouring permanently. Dye is usually avoided for around 4 to 6 weeks while the scalp settles, and after that you can colour as before, including the transplanted hair, which behaves like the rest.
The one caution is chemical processing during the shedding and early regrowth phase. Harsh treatments on a scalp that is still healing risk irritation, so it is worth asking the clinic for their timetable rather than assuming the usual one applies.
Choose between a female hair transplant and medication by what you are treating. A defined target such as a high hairline, recessed temples or traction alopecia responds well to grafting. Diffuse thinning across the top responds better to medication, because that is the pattern where the donor is likely affected too.
Many women end up doing both: treatment to hold what remains, surgery for the specific area that bothers them. A clinic that presents them as alternatives rather than as complements is oversimplifying the choice.
A female hair transplant is deferred until after pregnancy and breastfeeding, because the local anaesthetic and any medication involved are avoided, and because hormonal changes during and after pregnancy alter hair growth substantially.
Postpartum shedding is also extremely common and usually recovers on its own over 6 to 12 months. Operating during that period risks treating something that would have resolved, at a point when the whole scalp is unstable.
Minoxidil is the main medical treatment for female pattern loss and has reasonable evidence behind it, particularly for diffuse thinning across the top, which is exactly the pattern surgery handles worst.
It needs continuous use, and stopping means losing whatever benefit it produced over the following year. Other options exist and are prescribed depending on the diagnosis, which is a conversation for a doctor who knows your history.
NHS2024Regulator
American Society of Plastic Surgeons2024Professional society
Mayo Clinic2024Other
Consultation request
Tell us the procedure and destination you are considering. We forward your request to the verified clinic you select.